Modeling Clinical Outcomes in Gambling Addiction
ConditionGambling Disorder
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon
About this trial
Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental health consequences.
MOGADOR is a longitudinal, multicentric, prospective, prognostic study, which aims to identify factors predicting the evolution of french patients with GD in care centers particularly involved in the management of GD. The main goal will focus on evolution of DSM-5 (Diagnostic and Statistical Manual of Mental Disorder 5th edition) GD criteria during the first year of follow-up. The prognostic factors will be collected at base-line and they will be considered to influence the long-term prognosis of patients.
For patients suffering of GD, our main hypothesis is that initial factors like individual socio-demographic characteristics, clinical psychiatric profiles, addiction comorbidities, and behaviour are associated with the clinical prognosis (total remission of DSM-5 criteria of GD at 12 months).
MOGADOR will be the first study, aiming to model prognostic aspects of GB in populations specially monitored for this disorder.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient, male or female, over 18 years old, consulting in one of the participating centers.
DSM-5 criteria for gambling disorder at inclusion: at least 4 criteria present in the 12 months preceding the study.
First treatment for gambling disorder or no treatment in the last 6 months (initiation or re-initiation of care).
Disqualifiers
Unable to be reached by phone.
Unable to use the internet.
Patient under antiparkinsonian treatment of the dopaminergic family.
Being treated with a drug that may trigger/increase symptoms of gambling disorder (e.g. dopamine agonist).
Trial population
268 patients with gambling disorder according to DSM-5 criteria newly managed in one of the participating centers or who had an interruption in management of more than 6 months.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
268 Participants
are grouped into 1 trial groupGroup A: Patients with gambling disorder
Trial outcomes
Primary outcomes
1
Partial remission of gambling disorder at 12 months (strictly less than 4 DSM-5 criteria)
Assessment of DSM-5 criteria will be performed by the clinician, and by a previously trained CRA if clinical follow-up is discontinued.
Time frame
DSM-5 criteria assessment will be conducted at 9 and 12 months after inclusion.2
modeling prognostic factors
The prognostic factors, studied will be: number of initial DSM-5 criteria, gender, age, marital status, housing, employment status, socioeconomic level, time spent gambling, impulsivity, type of gambling, location of gambling, and also the factor with the strongest association in univariate analysis among the following factors: * Depression (PHQ scale), * Anxiety (GAD scale), * Quality of life (SF-36 scale).
Time frame
at inclusion visit.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: